About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Finally, Some Good News for Genentech on Avastin® | Main | (Finally) It May Be Time to Stop the Hypocrisy over Stem Cell Patents »

February 27, 2008

Comments

"The patent applicant has the most knowledge, the most opportunity, and the most to gain by providing the USPTO with the best possible information about his or her invention."

Unfortunately, this statement is grammatically incorrect. It also simplistically and incorrectly assumes (as a person without patent experience might) that patent applicants have "the most knowledge" of the prior art. In reality, inventors more often than not have no idea what research is being conducted on the other side of the globe (and may as of yet be unpublished), and they have *much* less knowledge of patented prior art than USPTO examiners should. Director Dudas would have inventors become researchers and examiners (rather than inventors), while at the same time dis-"incentivising" the public dissemination of their own inventions through rules expressly designed to deter and obstruct (e.g. through fictitious presumptions) patent application filings. This is no way to promote the progress of the useful arts - though it will reduce the agency's own discomfort with its backlog.

USPTO examiners should have "the most knowledge" of the prior art, and to the extent they don't, this should be considered a failing of the USPTO. To place the burden of assessing the prior art and examining the claims on the applicant only further reinforces the ever-intensifying questions: What do we need the USPTO for? What useful function does the USPTO perform? (In both instances, I am beginning to think, "Nothing!")

Thanks very much for this post. I had no idea that any such hearings were going to take place. At least there is some hope that some of the witnesses discussed some of the criticisms of the Patent Office brought out in the comments on the rules and the briefs in GSK/Tafas v. Dudas, and I look forward to hearing about them.

The comments to this entry are closed.

January 2020

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31